Abstract:Introduction: Nitroimidazole (azomycin) derivatives labeled with radioisotopes have been developed as cancer imaging and radiotherapeutic agents based on the oncological hypoxic mechanism. By attaching nitroimidazole core with different functional groups, we synthesized new nitroimidazole derivatives and evaluated their potentiality as tumor imaging agents.Methods: Starting with commercially available 2-nitroimidazole, 2-fluoro-N-(2-(2-nitro-1H-imidazol-1-yl)ethyl)acetamide (NEFA, [F-19]7) and 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl 2-fluoroacetate (NEFT, [F-19]8), as well as radiolabeling precursors, the bromo-substituted analogs were quickly synthesized through a three-step synthetic pathway. The precursors were radiolabeled with [F-18]F-/18-crown-6/KHCO3 in dimethyl sulfoxide at 90 degrees C for 10 min followed by purification with an Oasis HLB cartridge. Biodistribution studies were carried out in EMT-6 tumor-bearing mice. The uptake (%ID/g) in tumors and normal tissues were measured at 30 min postinjection. Liquid chromatography-electrospray ionization mass spectrometry (LC/MS) was used to distinguish metabolites from parent drugs in urine and plasma of rat injected with "cold" NEFA ([F-19]7) and NEFT ([F-19]8).Results: Two radiotracers, [F-18]NEFA ([F-18]7) and [F-18]NEFT ([F-18]8), were prepared with average yields of 6%-7% and 9%-10% (not decay corrected). Radiochemical purity for both tracers was >95% as determined by HPLC. Biodistribution studies in EMT-6 tumor-bearing mice indicated that the tumor to blood and tumor to liver ratios of both [F-18]7 (0.96, 0.61) and [F-18]8 (0.98, 1.10) at 30 min were higher than those observed for [F-18]FMISO (1) (0.91, 0.59), a well-investigated azomycin-type hypoxia radiotracer. Liquid chromatography-electrospray ionization mass spectrometry analysis demonstrated that fluoroacetate was the main in vivo metabolite for both NEFA ([F-19]7) and NEFT ([F-19]8).Conclusions: In this research, two new fluorine-18 labeled 2-nitroimidazole derivatives, [F-18]7 and [F-18]8, both of which containing in vivo hydrolyzable group, were successfully prepared. Further biological evaluations are warranted to investigate their potential as PET radioligands for imaging tumor. (C) 2011 Elsevier Inc. All rights reserved.

Synthesis and evaluation of (18)F-labeled tertiary benzenesulfonamides for imaging carbonic anhydrase IX expression in tumours with positron emission tomography.

Synthesis and evaluation of 18F-labeled carbonic anhydrase IX inhibitors for imaging with positron emission tomography.

Trimeric Radiofluorinated Sulfonamide Derivatives to Achieve in Vivo Selectivity for Carbonic Anhydrase IX-Targeted PET Imaging.

Synthesis and biological evaluation of a 99mTc-labelled sulfonamide conjugate for in vivo visualization of carbonic anhydrase IX expression in tumor hypoxia

Pet Imaging Of Carbonic Anhydrase Ix Expression Of Ht-29 Tumor Xenograft Mice With Ga-68-Labeled Benzenesulfonamides

Fluorine-18 click radiosynthesis and MicroPET/CT evaluation of a small peptide-a potential PET probe for carbonic anhydrase IX

Evaluation of 18 F-labeled Icotinib Derivatives As Potential PET Agents for Tumor Imaging

Imaging of Carbonic Anhydrase IX with an 111In-Labeled Dual-Motif Inhibitor

Synthesis and Evaluation of Two Novel 2-Nitroimidazole Derivatives As Potential Pet Radioligands for Tumor Imaging

18F-labeled Pyrazolo[1,5-a]pyrimidine Derivatives: Synthesis from 2,4-Dinitrobenzamide and Tosylate Precursors and Comparative Biological Evaluation for Tumor Imaging with Positron Emission Tomography

Synthesis and evaluation of an 18F-labeled boramino acid analog of aminosuberic acid for PET imaging of the antiporter system xC<sup/>

Synthesis and Evaluation of Novel F-18 Labeled 4-Aminoquinazoline Derivatives: Potential Pet Imaging Agents for Tumor Detection

Synthesis and evaluation of a (18) F-labeled 4-phenylpiperidine-4-carbonitrile radioligand for σ1 receptor imaging.

Design of Novel 18 F-Labeled Amino Acid Tracers Using Sulfur 18 F-Fluoride Exchange Click Chemistry

Synthesis and Evaluation of Novel 18f‐labeled Quinazoline Derivatives with Low Lipophilicity for Tumor PET Imaging

Synthesis and Evaluation of Novel Tropane Derivatives As Potential PET Imaging Agents for the Dopamine Transporter.

F-18-Labeled Pyrazolo[1,5-A]Pyrimidine Derivatives: Synthesis From 2,4-Dinitrobenzamide And Tosylate Precursors And Comparative Biological Evaluation For Tumor Imaging With Positron Emission Tomography

Synthesis and Biological Evaluation of Fluorine-18 and Deuterium Labeled l-Fluoroalanines as Positron Emission Tomography Imaging Agents for Cancer Detection

Synthesis and Evaluation of Novel F-18 Labeled Fluoroarylvaline Derivatives: Potential Pet Imaging Agents for Tumor Detection

Preclinical Evaluation of a High-Affinity 18F-Trifluoroborate Octreotate Derivative for Somatostatin Receptor Imaging

Novel 18F-Labeled Benzimidazolone-Based Radioligands As Highly Selective Sigma-2 Receptor Probes for Tumor Imaging